C-CAMP has partnered with Imperial College London to establish an Indo UK Life Sciences Innovation Corridor, aimed at accelerating cross border research, startup collaboration, and biotech innovation.
Glimpse:
Announced in April 2026, Centre for Cellular and Molecular Platforms (C-CAMP) and Imperial College London signed an MoU to create the Indo-UK Life Sciences Innovation Corridor. The initiative will enable collaboration between researchers, startups, and innovators across both countries, fostering joint research, funding opportunities, and knowledge exchange.
In a major step toward strengthening global biotech collaboration, Centre for Cellular and Molecular Platforms (C-CAMP), based in Bengaluru, has partnered with Imperial College London to launch the Indo-UK Life Sciences Innovation Corridor.
The partnership is built on a formal Memorandum of Understanding (MoU) and is designed as a long term framework to deepen collaboration between India and the UK in life sciences research, innovation, and entrepreneurship.
At its core, the corridor aims to create a cross border innovation ecosystem, bringing together researchers, startups, and industry stakeholders from both countries. It will facilitate the exchange of talent including scientists, innovators, and entrepreneurs while enabling collaborative research projects and commercialization opportunities.
A key feature of the initiative is a bi-directional exchange program, allowing UK-based teams to explore deployment opportunities in India, while Indian innovators can access markets in the UK and potentially Europe. This approach is expected to accelerate the translation of research into real-world healthcare and biotech solutions.
The corridor will also act as a platform for structured knowledge sharing, focusing on priority scientific challenges, innovation readiness, and ecosystem development. Additionally, both partners plan to explore joint fundraising and strategic partnerships to ensure long term sustainability and scalability of the initiative.
Leaders from both organizations highlighted that the collaboration connects two of the world’s leading biotech ecosystems Bengaluru and London creating a powerful bridge between academic research and real world applications.
Experts believe this initiative could significantly boost biotech innovation, startup growth, and translational research, positioning both India and the UK as key players in solving global health and life sciences challenges.
“This partnership creates a powerful bridge between research and entrepreneurship.”
By
HB Team
Related News
